HUP0202595A2 - A 11-es helyzetben szénhidrogéncsoportot hordozó nem aromás ösztrogén szteroidok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk - Google Patents

A 11-es helyzetben szénhidrogéncsoportot hordozó nem aromás ösztrogén szteroidok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk

Info

Publication number
HUP0202595A2
HUP0202595A2 HU0202595A HUP0202595A HUP0202595A2 HU P0202595 A2 HUP0202595 A2 HU P0202595A2 HU 0202595 A HU0202595 A HU 0202595A HU P0202595 A HUP0202595 A HU P0202595A HU P0202595 A2 HUP0202595 A2 HU P0202595A2
Authority
HU
Hungary
Prior art keywords
alkyl
group
alkenyl
alkynyl
hydrogen
Prior art date
Application number
HU0202595A
Other languages
English (en)
Inventor
Hubert Jan Jozef Loozen
Wilhelmus Gerardus Eduardus Joseph Schoonen
Gerrit Herman Veeneman
Original Assignee
Akzo Nobel N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel N.V. filed Critical Akzo Nobel N.V.
Publication of HUP0202595A2 publication Critical patent/HUP0202595A2/hu
Publication of HUP0202595A3 publication Critical patent/HUP0202595A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgya nem aromás A gyűrűt és a 3-as helyzetben szabadvagy helyettesített hidroxilcsoportot tartalmazó szteroidvázasösztrogén hatású vegyületek, ezeket tartalmazó gyógyszerkészítményekés alkalmazásuk. A találmány szerinti vegyületek (I) általánosképletében R1 jelentése hidrogénatom, alkil- vagy acilcsoport; R2jelentése hidrogénatom, a-alkil-, a-alkenil- vagy a-alkinil-csoport;R3 jelentése hidrogénatom, alkil-, alkenil- vagy alkinilcsoport,mindegyik a szteroid váz 15-ös vagy 16-os helyzetében; R4 jelentésehidrogénatom, alkil-, alkenil- vagy alkinilcsoport, ahol mindegyikmegadott csoport adott esetben halogénatommal lehet helyettesítve; R4előnyös jelentése etinilcsoport; R5 jelentése hidrogénatom, alkil-,vagy acilcsoport; R6 jelentése alkil-, alkenil-, alkinil- vagyalkilidéncsoport, ahol mindegyik megadott csoport adott esetbenhalogénatommal vagy alkoxicsoporttal lehet helyettesítve; és aszaggatott vonal jelentése adott esetben jelenlévő kettős kötés. Ó
HU0202595A 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11, pharmaceutical compositions containing them and their use HUP0202595A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202900 1999-09-06
PCT/EP2000/008406 WO2001018027A1 (en) 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11

Publications (2)

Publication Number Publication Date
HUP0202595A2 true HUP0202595A2 (hu) 2002-12-28
HUP0202595A3 HUP0202595A3 (en) 2004-06-28

Family

ID=8240610

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202595A HUP0202595A3 (en) 1999-09-06 2000-08-28 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11, pharmaceutical compositions containing them and their use

Country Status (24)

Country Link
US (1) US6677329B1 (hu)
EP (1) EP1224204B1 (hu)
JP (1) JP2003508541A (hu)
KR (1) KR20020092907A (hu)
CN (2) CN100354299C (hu)
AT (1) ATE295851T1 (hu)
AU (1) AU770331B2 (hu)
BR (1) BR0013769A (hu)
CA (1) CA2382489C (hu)
CZ (1) CZ2002831A3 (hu)
DE (1) DE60020260T2 (hu)
EC (1) ECSP013947A (hu)
ES (1) ES2241657T3 (hu)
HU (1) HUP0202595A3 (hu)
IL (2) IL148116A0 (hu)
MX (1) MXPA02001831A (hu)
NO (1) NO20021079L (hu)
NZ (1) NZ517281A (hu)
PL (1) PL353826A1 (hu)
RU (1) RU2245886C2 (hu)
SK (1) SK3282002A3 (hu)
TR (1) TR200200575T2 (hu)
WO (1) WO2001018027A1 (hu)
ZA (1) ZA200201250B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5209600A (en) * 1999-04-06 2000-10-23 Akzo Nobel N.V. Orally active androgens
HUP0202595A3 (en) * 1999-09-06 2004-06-28 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11, pharmaceutical compositions containing them and their use
US8173628B2 (en) * 2000-06-22 2012-05-08 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
US7041839B2 (en) * 2000-06-22 2006-05-09 Northeastern University Steroidal antiestrogens and antiandrogens and uses thereof
WO2002010188A1 (en) * 2000-07-28 2002-02-07 Akzo Nobel N.V. 16alpha-methyl or ethyl substituted estrogens
UA89964C2 (ru) 2004-09-08 2010-03-25 Н.В. Органон 15β-ЗАМЕЩЕННЫЕ СТЕРОИДЫ, КОТОРЫЕ ИМЕЮТ СЕЛЕКТИВНУЮ ЭСТРОГЕННУЮ АКТИВНОСТЬ
US11034716B2 (en) * 2016-03-03 2021-06-15 Crystal Pharma, S.A.U. Process and new intermediates for the preparation of 11-methylene steroids
CN114249789B (zh) * 2020-09-23 2023-06-02 湖南普尔生物医药有限公司 一种7α-甲基-3,3-二甲氧基-5(10)-雄烯-17-酮的制备方法
CN114409717B (zh) * 2021-12-17 2023-03-17 湖南科益新生物医药有限公司 替勃龙中间体醚化物和替勃龙的制备方法
CN114230627B (zh) * 2021-12-31 2023-09-15 湖南新合新生物医药有限公司 一种倍他米松环氧水解物中间体的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3092645A (en) 1961-12-28 1963-06-04 Searle & Co Esters of 17alpha-alkynylester-5(10)-ene-3beta, 17beta-diols
GB1112840A (en) 1964-04-07 1968-05-08 Res Inst Medicine Chem Steroids having pro-oestrogenic activity
US3465010A (en) 1966-11-22 1969-09-02 Searle & Co 17 - (unsaturated hydrocarbon - substituted) 11,13beta - dialkylgon -4 - ene - 3,17beta-diols and esters thereof
US3377366A (en) 1966-12-02 1968-04-09 Searle & Co 17alpha-alkynyl/alkenyl-11, 13beta-dialkylgon-5(10)-en-3-ones and esters thereof
US3652606A (en) 1970-08-07 1972-03-28 Searle & Co 3-oxygenated 11beta-methylestr-4-en-17beta-ol and esters thereof
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
ZA94715B (en) 1993-02-08 1994-10-24 Akzo Nv Steroids for treating menopausal complaints
ZA941464B (en) 1993-03-05 1994-09-27 Akzo Nv Use of pregnane derivative
TR200002593T2 (tr) 1998-03-09 2000-12-21 Akzo Nobel N.V. Yeni bir gebelik önleme kiti
HUP0202595A3 (en) * 1999-09-06 2004-06-28 Akzo Nobel Nv Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11, pharmaceutical compositions containing them and their use

Also Published As

Publication number Publication date
TR200200575T2 (tr) 2002-06-21
NZ517281A (en) 2003-09-26
ECSP013947A (es) 2002-09-27
CN100354299C (zh) 2007-12-12
JP2003508541A (ja) 2003-03-04
ATE295851T1 (de) 2005-06-15
PL353826A1 (en) 2003-12-01
SK3282002A3 (en) 2002-06-04
US6677329B1 (en) 2004-01-13
DE60020260T2 (de) 2006-01-19
DE60020260D1 (de) 2005-06-23
EP1224204A1 (en) 2002-07-24
AU7511700A (en) 2001-04-10
IL148116A0 (en) 2002-09-12
CZ2002831A3 (cs) 2002-05-15
CN1637016A (zh) 2005-07-13
KR20020092907A (ko) 2002-12-12
EP1224204B1 (en) 2005-05-18
RU2245886C2 (ru) 2005-02-10
ZA200201250B (en) 2003-07-30
HUP0202595A3 (en) 2004-06-28
AU770331B2 (en) 2004-02-19
CA2382489A1 (en) 2001-03-15
BR0013769A (pt) 2002-04-30
WO2001018027A1 (en) 2001-03-15
NO20021079D0 (no) 2002-03-05
IL148116A (en) 2006-10-31
MXPA02001831A (es) 2002-10-23
CN1372565A (zh) 2002-10-02
CA2382489C (en) 2008-03-11
CN1185249C (zh) 2005-01-19
NO20021079L (no) 2002-04-29
ES2241657T3 (es) 2005-11-01

Similar Documents

Publication Publication Date Title
HUP0000968A2 (hu) A 17alfa-helyzetben fluorozott alkilláncot tartalmazó antigesztagén szteroidok
AU582618B2 (en) New steroids substituted at position 10, the process and the intermediates for their preparation, their application as medicaments, the pharmaceutical compositions containing them
DE122012000012I1 (de) 17-Substituierte steroide, verwendbar bei behandlung von krebs.
DE69634039D1 (de) Neuroaktive steroide der androstan- und pregnanreihe
DK1446128T3 (da) Anvendelse af östrogenforbindelser i kombination med progestogenforbindelser i hormonsubstitutionsbehandling
HUP0202595A2 (hu) A 11-es helyzetben szénhidrogéncsoportot hordozó nem aromás ösztrogén szteroidok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
MX9304541A (es) Esteriodes de 17-espirometileno.
KR930017917A (ko) 스테로이드 유도체
KR950031081A (ko) 마약 또는 마약 혼합물 및 그들을 함유한 조성물의 작용을 자연스럽게 또는 급격히 중단함으로써 나타나는 증상과 관련된 증후군의 예방 또는 치료용 의약의 제조에 사용되는 항글루코코티코이드 활성을 갖는 화합물의 용도
KR940701260A (ko) 스테로이드 함유 안구용 약제조성물, 이것을 녹내장 치료에 사용하는 방법 및 이것의 제조방법
GB1508745A (en) Steroidal(16alpha,17-d)cyclohexenes
GB1495531A (en) 11beta-alkyl steroids of the estrane series
HUP0301592A2 (hu) 16alfa-metil- vagy etil-szubsztituált ösztrogének és ezeket tartalmazó gyógyszerkészítmények
EE200300124A (et) 17alfa-fluoroalküülsteroidid, nende valmistamismeetod ja neid ühendeid sisaldavad farmatseutilised kompositsioonid
ATE40140T1 (de) Aromatase inhibierende steroide.
ATE154606T1 (de) 2beta,19-methylenamin überbrückte steroide als aromatasehemmer
AR010857A1 (es) Esteroides sustituidos en la posicion 11, su procedimiento de preparacion, su aplicacion como medicamento y las composiciones farmaceuticas que loscontienen
GB1297962A (hu)
GB1087585A (en) Improvements in or relating to tetrahydropyranylethers of steroids
YU151591A (sh) Postupak za etinilovanje 17-ketosteroida
CA2431355A1 (en) 14.beta., 16,17-methylene steroids as novel androgens
TH20172B (th) สารสำเร็จรูปในทางเภสัชกรรมที่มีอนุพันธ์เอสทรา-1,3,5(10)-ไทรอีน